New presidency

Siemens Healthineers names Deepak Nath head of laboratory diagnostics

Siemens Healthineers has appointed Dr. Deepak Nath as President of Laboratory Diagnostics effective February 1.

Photo
Deepak Nath, the new head of laboratory diagnostics
Source: Siemens Healthineers

Nath succeeds Franz Walt, who served from 2014-2017, and led the business during its launch of the Atellica Solution. Nath will continue the endeavor to transform care delivery in the laboratory by growing the business, leveraging his extensive operational experience in healthcare. He will be based in Tarrytown, NY. “Siemens Healthineers seeks to benefit from market opportunities in the diagnostics market through the introduction of Atellica Solution,” said Michael Reitermann, Chief Operating Officer, Siemens Healthineers. “Deepak Nath’s exceptional leadership experience and deep industry knowledge will greatly benefit us as we look to expand the early success of Atellica Solution and drive wide adoption in the diagnostics market.”

Nath brings 20 years of wide-ranging leadership experience in healthcare to Siemens Healthineers, including general management, strategy, R&D, commercial operations and change management. For the past three years, Nath served as president of Abbott’s vascular division and as an executive officer of the company. His 10-year career there also comprised a variety of global leadership roles, including president of the molecular diagnostics division, divisional vice president and general manager of Ibis Biosciences, and several commercial leadership positions across mature and emerging markets. Earlier in his career he held positions at Amgen, where he lead process improvement initiatives; at McKinsey, serving a range of clients in the medical device and pharma industries; and as a scientist in the computational physics group at the Lawrence Livermore National Laboratory. Nath has B.S and M.S degrees in Mechanical Engineering and a Ph.D. in Theoretical Mechanics, all from the University of California, Berkeley.


Source: Siemens Healthineers

30.01.2018

Read all latest stories

Related articles

Photo

Improvement of cardiac care

Rapid myocardial infarction verification

The use of troponin assays to rule in or rule out myocardial infarction (MI) rapidly is critical on several levels. The quick result can reassure the patient that they have not had a heart attack and…

Photo

Innovation

AI helpers simplify clinical MRI scans

The new 1.5 Tesla MRI from Siemens Healthineers, Magnetom Sola, is packed with helpful algorithms and other functions. AI-supported systems monitor patients and scan parameters and ensure consistent…

Photo

Lab equipment

It takes a team

Clinical laboratories need to meet greater testing demands, improve efficiency, and deliver reliable, high-quality results, while at the same time, facing an increasing shortage of skilled employees…

Related products